The sustainable way to resolve the burden of chronic diseases is prevention. Our blood analysis service enables early disease risk prediction at both the individual and population level.
Predictive and preventative healthcare
Clinical blood biomarker analysis
Current risk models are typically based on a limited number of measurements, leading to a “one-size-fits-all” approach that can be costly and fail patients. Healthcare experts widely acknowledge that there now needs to be a shift towards precision medicine. Our blood analysis service has the ability to stratify patients, taking into account the individual differences in phenotype, a crucial next step towards achieving a more personalized approach.
With Nightingale's service, physicians will be able to identify, follow up, and reclassify patients with greater accuracy according to their individual disease risk. The ability to utilize health information in real-time will liberate physicians to provide more personalized guidance to patients and improve the effectiveness of treatment interventions - a true healthcare revolution.
Empowering patients to take control
Heart disease, diabetes and other chronic diseases often develop without symptoms, resulting in heavy burdens for both patients and healthcare systems. Sufferers of chronic diseases can struggle with disease management and disease progression can lead to severe health complications.
Nightingale’s service enables early identification of disease risk through metabolic profiling, empowering patients to take better control over their own health. By enabling early identification of the onset of chronic diseases we can also effectively target medications, prescribing treatments to the right patient groups and avoiding overmedication.
Population-level health screening
The ability to clinically track human health at both the patient and population level provides transformative possibilities for governments to build effective nationwide health policies. Rapid and accurate disease risk profiling predicts health outcomes and allows responsive feedback on the effect of drug and lifestyle intervention strategies.
Realizing preventive healthcare
Nightingale's blood analysis service has been designed with a healthcare setting in mind from the start. The power of our biomarker panel to provide accurate risk prediction will continue to improve as we include additional biomarkers and build novel risk scores based on large population cohorts.